Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2022
Effect of Dexamethasone on Dyspnoea in Patients With Cancer (Abcd): A Parallel-Group, Double-Blind, Randomised, Controlled Trial, David Hui, Veronica Puac, Zeena Shelal, et al.
miR21 Modulates the Hippo Signaling Pathway via Interference With PP2A Bβ to Inhibit Trophoblast Invasion and Cause Preeclampsia, Mingyu Hu, Yangxi Zheng, Jiujiang Liao, et al.
Evolution and Modulation of Antigen-Specific T Cell Responses in Melanoma Patients, Jani Huuhtanen, Liang Chen, Emmi Jokinen, et al.
Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction-Reconstruction and Fragment-Growing Approach, Giulia Iannelli, Ciro Milite, Nils Marechal, et al.
Activated B Cells Suppress T-Cell Function Through Metabolic Competition, Nobuhiko Imahashi, Rafet Basar, Yuefan Huang, et al.
Radiation Therapy Induces Immunosenescence Mediated by P90RSK, Masaki Imanishi, Haizi Cheng, Sivareddy Kotla, et al.
A Comprehensive Search of Non-Canonical Proteins in Non-Small Cell Lung Cancer and Their Impact on the Immune Response, Ehsan Irajizad, Johannes F Fahrmann, James P Long, et al.
A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses, Ehsan Irajizad, Chae Y Han, Joseph Celestino, et al.
Application of Artificial Intelligence to Plasma Metabolomics Profiles to Predict Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer, Ehsan Irajizad, Ranran Wu, Jody Vykoukal, et al.
Low-Dose Dasatinib 50 mg/Day Versus Standard-Dose Dasatinib 100 mg/Day As Frontline Therapy in Chronic Myeloid Leukemia in Chronic Phase: A Propensity Score Analysis, Elias Jabbour, Koji Sasaki, Fadi G Haddad, et al.
Response to Brentuximab Vedotin by CD30 Expression in Non-Hodgkin Lymphoma, Deepa Jagadeesh, Steve Horwitz, Nancy L Bartlett, et al.
Metabolic Stress Induces GD2+ Cancer Stem Cell-Like Phenotype in Triple-Negative Breast Cancer, Appalaraju Jaggupilli, Stanley Ly, Khoa Nguyen, et al.
Inhibition of Cyclin Dependent Kinase 4/6 Overcomes Primary Resistance to Programmed Cell Death 1 Blockade in Malignant Mesothelioma, Hee-Jin Jang, Cynthia Y Truong, Eric M Lo, et al.
Histopathological Tumour Response Scoring in Resected Pancreatic Cancer Following Neoadjuvant Therapy: International Interobserver Study (ISGPP-1), Boris V Janssen, Stijn van Roessel, Susan van Dieren, et al.
Use of the Fully Spectroscopic Pixelated Cadmium Telluride Detector for Benchtop X-Ray Fluorescence Computed Tomography, Sandun Jayarathna, Hem Moktan, and Sang Hyun Cho
Landscape of NOTCH1 Mutations and Co-occurring Biomarker Alterations in Chronic Lymphocytic Leukemia, Fatima Zahra Jelloul, Richard Yang, Sofia Garces, et al.
Broad-Acting Therapeutic Effects of miR-29b-Chitosan on Hypertension and Diabetic Complications, David M Jensen, Peng Han, Lingegowda S Mangala, et al.
Examining Rural-Urban Differences in Fatalism and Information Overload: Data from 12 NCI-Designated Cancer Centers, Jakob D Jensen, Jackilen Shannon, Ronaldo Iachan, et al.
Mutations of the DNA Repair Gene PNKP in a Patient With Microcephaly, Seizures, and Developmental Delay (MCSZ) Presenting With a High-Grade Brain Tumor, Bingcheng Jiang, Cameron Murray, Bonnie L Cole, et al.
TIGIT Is the Central Player in T-Cell Suppression Associated With CAR T-Cell Relapse in Mantle Cell Lymphoma, Vivian Changying Jiang, Dapeng Hao, Preetesh Jain, et al.
scGWAS: Landscape of Trait-Cell Type Associations by Integrating Single-Cell Transcriptomics-Wide and Genome-Wide Association Studies, Peilin Jia, Ruifeng Hu, Fangfang Yan, et al.
Severe Radiation-Induced Lymphopenia Attenuates the Benefit of Durvalumab After Concurrent Chemoradiotherapy for NSCLC, Wang Jing, Ting Xu, Lirong Wu, et al.
Prognostic Model for Predicting Overall and Cancer-Specific Survival Among Patients With Superficial Spreading Melanoma: A SEER Based Study, Qiang Ji, Jun Tang, Shulian Li, et al.
Phase II Study of Durvalumab (Anti-Pd-L1) and Trametinib (MEKi) in Microsatellite Stable (Mss) Metastatic Colorectal Cancer (mCRC), Benny Johnson, Cara L Haymaker, Edwin R Parra, et al.
Inhibition of the Phosphatidylinositol-3 Kinase Pathway Using Bimiralisib in Loss-of-Function NOTCH1-Mutant Head and Neck Cancer, Faye M Johnson, Filip Janku, Mohamed A Gouda, et al.